SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Sandra Hoffmann, Julia Böhme, Christian Kube, Jörg Haufe, Maria-Elisabeth Krautwald-Junghanns, Getu Abraham, Differential regulation of the β-adrenoceptor density and cyclic AMP level with age and sex in turkey cardiac chambers, European Journal of Pharmacology, 2016, 777, 88

    CrossRef

  2. 2
    Adriana Adameova, Yasser Abdellatif, Naranjan S. Dhalla, Role of the excessive amounts of circulating catecholamines and glucocorticoids in stress-induced heart disease, Canadian Journal of Physiology and Pharmacology, 2009, 87, 7, 493

    CrossRef

  3. 3
    Oleg E. Osadchii, Cardiac hypertrophy induced by sustained β-adrenoreceptor activation: pathophysiological aspects, Heart Failure Reviews, 2007, 12, 1, 66

    CrossRef

  4. 4
    Peter Molenaar, Lu Chen, William A Parsonage, Cardiac implications for the use of β2-adrenoceptor agonists for the management of muscle wasting, British Journal of Pharmacology, 2006, 147, 6
  5. 5
    Doreen Sarsero, Peter Molenaar, Alberto J. Kaumann, Validity of (−)-[3H]-CGP 12177A as a radioligand for the ‘putative β4-adrenoceptor’ in rat atrium, British Journal of Pharmacology, 1998, 123, 3
  6. 6
    Peter Molenaar, Doreen Sarsero, Alberto J. Kaumann, PROPOSAL FOR THE INTERACTION OF NON-CONVENTIONAL PARTIAL AGONISTS AND CATECHOLAMINES WITH THE ‘PUTATIVE (β-ADRENOCEPTOR’ IN MAMMALIAN HEART, Clinical and Experimental Pharmacology and Physiology, 1997, 24, 9-10
  7. 7
    D. H. -T. Chang, R. Einstein, Changes in cardiovascular responsiveness to dopexamine and β1- and β2-adrenoceptor function after the chronic treatment of β-adrenoceptor antagonists and agonists in anaesthetized dogs, Journal of Autonomic Pharmacology, 1996, 16, 5